» Articles » PMID: 35800749

Systematic Review and Meta-analysis: Diagnostic Value of Different Ultrasound for Benign and Malignant Thyroid Nodules

Overview
Journal Gland Surg
Specialty Endocrinology
Date 2022 Jul 8
PMID 35800749
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conventional ultrasound and contrast-enhanced ultrasound (CEUS) are commonly used in the diagnosis of benign and malignant thyroid nodules. However, the value of the two methods in the diagnosis of benign and malignant thyroid nodules remains controversial.

Methods: PubMed, Medline, EBSCO, Science Direct, Cochrane Library, China National Knowledge Infrastructure (CNKI) database and manual journal retrieval were searched from January 2000 to January 2022, to include research on conventional ultrasound or CEUS in the diagnosis of benign and malignant thyroid nodule related clinical studies. Meta-analysis was conducted using RevMan5.3 and Stata Corp to analyze the sensitivity and specificity of conventional ultrasound and CEUS in the diagnosis of benign and malignant thyroid nodules with 95% confidence interval (CI) as indicators. Heterogeneity of the results was evaluated by Q test and I in RevMan5.3. Deek's method was used to evaluate publication bias.

Results: A total of 1,378 nodules were included in 11 literatures, including 535 malignant thyroid nodules and 843 benign thyroid nodules. Heterogeneity tests conducted for CEUS diagnostic sensitivity of the 6 included literatures indicated that there was no heterogeneity among the study groups [Q=2.05, degree of freedom (df) =5.00, I=0.00%, P=0.84]. The combined sensitivity was 0.87, with 95% confidence interval (CI): 0.82 to 0.90. Heterogeneity tests on the diagnostic specificity of CEUS of the six included literatures suggested that there was heterogeneity among the different study groups (Q=14.27, df =5.00, I=64.96%, P=0.01). The combined specificity was 0.84 (95% CI: 0.78 to 0.89). Heterogeneity tests performed on the sensitivity of five conventional ultrasound diagnosis articles revealed that there was heterogeneity among different study groups (Q=13.62, df =4.00, I=70.64%, P=0.01). The combined sensitivity was 0.86 (95% CI: 0.78 to 0.92). Heterogeneity tests on the specificity of conventional ultrasound diagnosis in five included literatures indicated that there was heterogeneity among different study groups (Q=16.94, df =4.00, I=76.39%, P=0.00). The combined specificity was 0.84 (95% CI: 0.75 to 0.90). There was no bias in the included literature.

Discussion: The sensitivity of CEUS in the diagnosis of benign and malignant thyroid nodules was slightly higher than that of conventional ultrasound, which provides a reference for the clinical diagnosis of benign and malignant thyroid nodules.

Citing Articles

The Utility of Contrast-Enhanced Ultrasound (CEUS) in Assessing the Risk of Malignancy in Thyroid Nodules.

Zylka A, Dobruch-Sobczak K, Piotrzkowska-Wroblewska H, Jedrzejczyk M, Bakula-Zalewska E, Goralski P Cancers (Basel). 2024; 16(10).

PMID: 38791990 PMC: 11119249. DOI: 10.3390/cancers16101911.


Management of Thyroid Nodules.

Uludag M, Unlu M, Kostek M, Aygun N, Caliskan O, Ozel A Sisli Etfal Hastan Tıp Bul. 2023; 57(3):287-304.

PMID: 37900341 PMC: 10600596. DOI: 10.14744/SEMB.2023.06992.


Ultrasound super-resolution imaging for the differential diagnosis of thyroid nodules: A pilot study.

Zhang G, Yu J, Lei Y, Hu J, Hu H, Harput S Front Oncol. 2022; 12:978164.

PMID: 36387122 PMC: 9647016. DOI: 10.3389/fonc.2022.978164.

References
1.
Yan L, Li X, Xiao J, Li Y, Zhu Y, He H . Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study. Int J Hyperthermia. 2021; 39(1):40-47. DOI: 10.1080/02656736.2021.1991009. View

2.
Gild M, Chan M, Gajera J, Lurie B, Gandomkar Z, Clifton-Bligh R . Risk stratification of indeterminate thyroid nodules using ultrasound and machine learning algorithms. Clin Endocrinol (Oxf). 2021; 96(4):646-652. DOI: 10.1111/cen.14612. View

3.
Thedinger W, Raman E, Dhingra J . Comparative Study of ACR TI-RADS and ATA 2015 for Ultrasound Risk Stratification of Thyroid Nodules. Otolaryngol Head Neck Surg. 2021; 167(1):35-40. DOI: 10.1177/01945998211064607. View

4.
Zhan J, Ding H . Application of contrast-enhanced ultrasound for evaluation of thyroid nodules. Ultrasonography. 2018; 37(4):288-297. PMC: 6177690. DOI: 10.14366/usg.18019. View

5.
Ghai S, OBrien C, Goldstein D, Sawka A . Ultrasound in active surveillance for low-risk papillary thyroid cancer: imaging considerations in case selection and disease surveillance. Insights Imaging. 2021; 12(1):130. PMC: 8446145. DOI: 10.1186/s13244-021-01072-9. View